Nuformix plc
NFX.L · LSE
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -29.94% | -72.05% | -0.01% | 1.92% |
| EV / EBITDA | 266.86 | -0.92 | -5,523.08 | -6.50 |
| Quality | ||||
| ROIC | -0.05% | -509.97% | -0.01% | -5.61% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.00 | 0.09 | 0.70 | -0.16 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 270.47 | 0.04 | 784.21 | 0.77 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,416.49 | 0.00 | -2,673.65 | -1,094.10 |